The amount of the transaction was not disclosed.
The company intends to use the funds to continue to grow operations.
Founded in 2012 by Dr. Tarun Jolly, CEO, Renaissance RX specializes in pharmacogenetic testing, which identifies how patients respond to medications based on their unique genetic makeup. The information Renaissance RX provides allows physicians to prescribe medications that work for each person.
The company processes thousands of tests daily and provides testing in 43 states across the country.